Dr. Mishra (Ex-Genentech, Ex-NCI, Ex-NIH) is the founding president and CEO of the American Association for Precision Medicine (AAPM) and chair of ACT –AAPM’s Coronavirus Taskforce. He is leading research efforts focused on preventing & curing chronic diseases; not only treating the sick but also providing knowledge/tools to individuals to live longer, healthier lives. He is also the founder and CEO of Agility Pharmaceuticals, a pharmaceutical company committed to revolutionizing drug discovery & development through technology, big data, robotics, and artificial intelligence. He is a serial entrepreneur who founded his first company after graduating high school, and his second company during his Ph.D. Since then, he has accumulated a wealth of experience by building, investing, and advising numerous other companies. He is an investor, co-founder/ board member of a few corporations, focused on accelerating drug discovery/ development, data analytics, robotics, mental health, and digital health. He is also the founder of AAPM Angels and Investors (AAi), an investment group focused on investing in drug discovery, diagnostics, precision medicine, technology & healthcare companies. He is also the founding investor and advisor to Barcelona Ventures and serves as an advisor to a $100M private equity fund.